Document is current
Any future updates will be listed below
-
Authors
Chan, Linda
Yu, Esther Yee Tak
Wan, Eric Yuk Fai
Wong, Samuel Yeung Shan
Chao, David Vai Kiong
Ko, Welchie Wai Kit
Chen, Catherine Xiao Rui
Chan, Paul Po Ling
Bilney, Emma Victoria Marianne
Lee, Eng Sing
Ng, Wei Leik
Lam, Cindy Lo Kuen
-
Funding
Funding for this research was provided by:
Health and Medical Research Fund (18191751)
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 13 March 2025
First Online: 31 March 2025
Declarations
:
: Ethical approval was granted by the Institutional Review Boards of the 4 participating Hospital Authority clusters (Additional file 1: Table S1). Ethical approval was granted by the Institutional Review Board of the University of Hong Kong / Hospital Authority Hong Kong West Cluster (reference no. UW 21–363), Research Ethics Committee Kowloon Central / Kowloon East (reference no. KC/KE-21–0137/ER-2), Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (reference no. 2021.283), and Research Ethics Committee Kowloon Central / Kowloon East (reference no. KC/KE-21–0144/ER-2). All participants provided written consent to be involved in the study.
: Not applicable.
: E.Y.F.W. has received research grants from the Health Bureau, the Hong Kong Research Grants Council, Narcotics Division, Security Bureau, Social Welfare Department, Labour and Welfare Bureau of the Government of the Hong Kong SAR and National Natural Science Foundation of China; serves on member of Core Team for Expert Group on Drug Registration of Pharmacy and Poisons Board, and is the director of Advance Data Analytics for Medical Science (ADAMS) Limited (HK). These are outside the submitted work. All other authors declare no competing interests.
